Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term special drug use surveillance of Metact Combination Tablets in type 2 diabetes mellitus
jRCT1080222318
- Sponsor
- Takeda
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metformin + pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
metformin + pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222318.